Shares of Hologic Inc. (NSDQ:HOLX) dipped 2 percent to $19.54 today after the women’s health company said its first-quarter profits plunged 58 percent.
Bedford, Mass.-based Hologic reported net income of $10.9 million, or 4 cents per diluted share, on sales of $432.6 million during the three months ended Dec. 25, 2010.
Adjusted for $68.9 million in one-time expenses, however, EPS reached 30 cents, narrowly beating analysts’ consensus expectation of 28 cents per share.
Hologic citedits breast health, gynecological surgery and skeletal health product lines for the top-line growth. Diagnostics revenues were off nearly 1 percent.
Looking ahead, the company predicted sales growth of 3 percent for its second quarter, compared with Q2 2010. Adjusted EPS is expected to be about 28 cents, compared with 29 cents during the same period last year. Full-year adjusted EPS is pegged at $1.22 to $1.24 on sales of $1.73 billion to $1.76 billion.